Literature DB >> 3492464

RBE of a thermal neutron beam and the 10B(n, alpha)7Li reaction on cultured B-16 melanoma cells.

H Fukuda, T Kobayashi, T Matsuzawa, K Kanda, M Ichihashi, Y Mishima.   

Abstract

The RBE of a thermal neutron beam and the 10B(n, alpha)7Li reaction were determined in cultured B-16 melanoma cells. The Kyoto University Research Reactor (KUR) was used as a thermal neutron source which had a very low contamination of gamma-rays and fast neutrons. The cells were irradiated with the beam in the presence or absence of 10B-boric acid. The absorbed dose from the neutron capture reaction to the cells was calculated by a method of Kitao (1975). Survival curves in both conditions had no shoulder and Do values were 0.506 or 0.604 Gy in the presence or absence of 5 micrograms 10B/ml-medium, respectively. The Do value of the 10B(n, alpha)7Li reaction was also estimated at 0.466 Gy, assuming each component of radiation was additive. The RBEs of the KUR thermal neutron beam and the 10B(n, alpha)7Li reaction relative to 60Co gamma-rays were estimated as 4.62 and 6.01 at 0.1 surviving fraction, respectively. Using these results, we calculated the absorbed dose from the 10B-compound and estimated the specific accumulation in the cultured cells of 10B-compounds which we have previously reported but not quantified (Nakanishi et al. 1980, Ichihashi et al. 1982).

Entities:  

Mesh:

Year:  1987        PMID: 3492464     DOI: 10.1080/09553008714550601

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  3 in total

1.  DNA double-strand break induction in Ku80-deficient CHO cells following boron neutron capture reaction.

Authors:  Yuko Kinashi; Sentaro Takahashi; Genro Kashino; Ryuichi Okayasu; Shinichiro Masunaga; Minoru Suzuki; Koji Ono
Journal:  Radiat Oncol       Date:  2011-09-05       Impact factor: 3.481

2.  Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses.

Authors:  Junichi Hiratsuka; Nobuhiko Kamitani; Ryo Tanaka; Eisaku Yoden; Ryuji Tokiya; Minoru Suzuki; Rolf F Barth; Koji Ono
Journal:  Cancer Commun (Lond)       Date:  2018-06-19

Review 3.  Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using 10B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results.

Authors:  Hiroshi Fukuda
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.